Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

DPHARMA

Final Dividend (with Dividend Re-Investment Plan)

DUOPHARMA BIOTECH BERHAD

EX-date 26 Jun 2019
Entitlement date 27 Jun 2019
Entitlement time 05:00 PM
Entitlement subject Final Dividend (with Dividend Re-Investment Plan)
Entitlement description Final Single-Tier Dividend of RM0.04 per ordinary share
Period of interest payment   to  
Financial Year End 31 Dec 2018
Share transfer book & register of members will be   to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no Tricor Investor & Issuing House Services Sdn Bhd Unit 32-01, Level 32, Tower A, Vertical Business Suite Avenue 3, Bangsar South No. 8, Jalan Kerinchi 59200 Kuala Lumpur Tel No. : 03-2783 9299 Fax No. : 03-2783 9222
Payment date 26 Jul 2019
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 27 Jun 2019
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator Currency
Currency Malaysian Ringgit (MYR)
Entitlement in Currency 0.04
Par Value (if applicable)


Remarks :
The Board of Directors of Duopharma Biotech Berhad ("Duopharma" or the "Company") ("Board") has proposed final single-tier dividend of RM0.04 per ordinary share in Duopharma ("Duopharma Shares") ("Dividend") for the financial year ended 31 December 2018. 

On 31 May 2019, the shareholders of Duopharma had at the Company's Eighteenth Annual General Meeting approved the Dividend and authorised the Board to allot and issue such number of new Duopharma Shares from time to time as may be required to be allotted and issued pursuant to the dividend reinvestment plan ("DRP"). 

On behalf of the Board, UOB Kay Hian Securities (M) Sdn Bhd had, on 13 June 2019, announced that the issue price of the new Duopharma Shares to be issued pursuant to the implementation of the DRP has been fixed at RM1.20 per Duopharma Share. 

This announcement is dated 13 June 2019.


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 13 Jun 2019
Category Entitlement(Notice of Book Closure)
Reference Number ENT-13062019-00002